Home › NCT06373861

Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY)

Generating Advancements Through Longitudinal Analysis in X and Y Variations

Who can join

0 Days – 100 Years · All sexes · Healthy volunteers welcome

Inclusion Criteria:

1. Genetically-confirmed diagnosis of a sex chromosome aneuploidy condition
2. Any age
3. Any gender
4. Informed consent for individuals \>18 years of age, parent/guardian permission for individuals \<18 or proxy-consent from legally authorized representative if impaired decision making

Exclusion Criteria:

a. Lack of documentation of genetic testing confirming SCA diagnosis

About the study

GALAXY is a registry research study that plans to learn more about individuals with X\&Y variations (also called sex chromosome aneuploidies) through collecting information from medical records.This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of clinics across the US. The purpose of the GALAXY Registry is to collect and store this information with the overall goal to improve health outcomes in individuals with X\&Y variations and the care they receive.

What is being tested

• no intervention (other)

Sponsor: University of Colorado, Denver · Participants: 5,000 · Started: Apr 28, 2022

Contact the study team

• Shanlee M Davis, MD, PhD · Phone: 720-777-6073

Official record on ClinicalTrials.gov — NCT06373861

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.